The iStent is a Promising New Treatment for Glaucoma Patients that also Need Cataract Surgery It is a promising era for glaucoma patients. On June 25, 2012, the Food & Drug Administration (FDA) approved the iStent Trabecular Micro-Bypass Stent System, Model GTS100R/L. The iStent is the first device ever approved to be used in conjunction with cataract surgery for adults with moderate open angle glaucoma.
DISCLAIMER: The information on this website is for educational purposes only. The information on this website is not meant to diagnose or treat any disease(s). Only a licensed doctor can diagnose or treat disease. No information on this website has been evaluated by the U.S. Food and Drug Administration.